11/24
04:05 pm
cdna
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
Low
Report
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
11/20
01:33 pm
cdna
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
06:01 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/10
08:00 am
cdna
CareDx to Participate in Upcoming Investor Conferences
Medium
Report
CareDx to Participate in Upcoming Investor Conferences
11/9
01:11 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Medium
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
11/7
04:34 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/7
04:05 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/6
08:10 am
cdna
CareDx (NASDAQ:CDNA) had its price target raised by analysts at BTIG Research from $22.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
CareDx (NASDAQ:CDNA) had its price target raised by analysts at BTIG Research from $22.00 to $25.00. They now have a "buy" rating on the stock.
11/6
08:00 am
cdna
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
High
Report
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
11/4
10:23 pm
cdna
CareDx, Inc (CDNA) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
CareDx, Inc (CDNA) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/4
05:19 pm
cdna
CareDx: Q3 Earnings Snapshot [Yahoo! Finance]
Low
Report
CareDx: Q3 Earnings Snapshot [Yahoo! Finance]
11/4
04:05 pm
cdna
CareDx Announces Third Quarter 2025 Financial Results
Medium
Report
CareDx Announces Third Quarter 2025 Financial Results
10/28
01:31 am
cdna
Low
Report
10/27
07:05 am
cdna
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
Medium
Report
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
10/23
04:05 pm
cdna
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
Low
Report
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
10/22
04:01 pm
cdna
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
Low
Report
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
10/22
06:56 am
cdna
CareDx (NASDAQ:CDNA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
CareDx (NASDAQ:CDNA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/21
08:00 am
cdna
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
Low
Report
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
10/20
01:04 am
cdna
Medium
Report
10/12
01:08 am
cdna
Low
Report
10/6
07:30 am
cdna
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting [Yahoo! Finance]
Medium
Report
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting [Yahoo! Finance]
10/6
07:05 am
cdna
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
Medium
Report
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
10/4
03:06 am
cdna
Low
Report
9/23
08:07 am
cdna
CareDx (NASDAQ:CDNA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock.
Medium
Report
CareDx (NASDAQ:CDNA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock.
9/12
08:03 am
cdna
CareDx (NASDAQ:CDNA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock.
Low
Report
CareDx (NASDAQ:CDNA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock.